Functional gastrointestinal disorders: An update for the psychiatrist

Michael P. Jones; Michael D. Crowell; Kevin W. Olden; Francis Creed

doi:10.1176/appi.psy.48.2.93

Functional gastrointestinal disorders: An update for the psychiatrist

Michael P. Jones, Michael D. Crowell, Kevin W. Olden, Francis Creed

Research output: Contribution to journal › Article › peer-review

Abstract

Functional gastrointestinal disorders (FGID) are common conditions, with well-established diagnostic criteria. They are associated with impaired health-related quality of life and increased societal and healthcare costs. Their symptoms are probably related to altered 5-HT transmission and central processing of noxious visceral stimuli. Evaluation and treatment are best formulated using a biopsychosocial model that integrates gut function with psychosocial assessment. Psychological therapies may improve overall well-being and appear to help patients without significant psychiatric comorbidity. Antidepressants help comorbid anxiety and depressive disorders and have primary efficacy in improving the symptoms of FGID. Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients. Copyright © 2007 The Academy of Psychosomatic Medicine.

Original language	English
Pages (from-to)	93-102
Number of pages	9
Journal	Psychosomatics
Volume	48
Issue number	2
DOIs	https://doi.org/10.1176/appi.psy.48.2.93
Publication status	Published - Mar 2007

Keywords

therapeutic use: Antidepressive Agents
drug therapy: Anxiety
Comorbidity
drug therapy: Depressive Disorder
epidemiology: Gastrointestinal Diseases
Health Care Costs
Health Surveys
Humans
Psychiatry
Psychotherapy
Quality of Life
drug therapy: Somatoform Disorders

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1176/appi.psy.48.2.93

Cite this

@article{00c6537b85744f86a986e4c1e3eda9d7,

title = "Functional gastrointestinal disorders: An update for the psychiatrist",

abstract = "Functional gastrointestinal disorders (FGID) are common conditions, with well-established diagnostic criteria. They are associated with impaired health-related quality of life and increased societal and healthcare costs. Their symptoms are probably related to altered 5-HT transmission and central processing of noxious visceral stimuli. Evaluation and treatment are best formulated using a biopsychosocial model that integrates gut function with psychosocial assessment. Psychological therapies may improve overall well-being and appear to help patients without significant psychiatric comorbidity. Antidepressants help comorbid anxiety and depressive disorders and have primary efficacy in improving the symptoms of FGID. Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients. Copyright {\textcopyright} 2007 The Academy of Psychosomatic Medicine.",

keywords = "therapeutic use: Antidepressive Agents, drug therapy: Anxiety, Comorbidity, drug therapy: Depressive Disorder, epidemiology: Gastrointestinal Diseases, Health Care Costs, Health Surveys, Humans, Psychiatry, Psychotherapy, Quality of Life, drug therapy: Somatoform Disorders",

author = "Jones, {Michael P.} and Crowell, {Michael D.} and Olden, {Kevin W.} and Francis Creed",

year = "2007",

month = mar,

doi = "10.1176/appi.psy.48.2.93",

language = "English",

volume = "48",

pages = "93--102",

journal = "Psychosomatics",

issn = "0033-3182",

publisher = "American Psychiatric Publishing Inc",

number = "2",

}

TY - JOUR

T1 - Functional gastrointestinal disorders: An update for the psychiatrist

AU - Jones, Michael P.

AU - Crowell, Michael D.

AU - Olden, Kevin W.

AU - Creed, Francis

PY - 2007/3

Y1 - 2007/3

N2 - Functional gastrointestinal disorders (FGID) are common conditions, with well-established diagnostic criteria. They are associated with impaired health-related quality of life and increased societal and healthcare costs. Their symptoms are probably related to altered 5-HT transmission and central processing of noxious visceral stimuli. Evaluation and treatment are best formulated using a biopsychosocial model that integrates gut function with psychosocial assessment. Psychological therapies may improve overall well-being and appear to help patients without significant psychiatric comorbidity. Antidepressants help comorbid anxiety and depressive disorders and have primary efficacy in improving the symptoms of FGID. Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients. Copyright © 2007 The Academy of Psychosomatic Medicine.

AB - Functional gastrointestinal disorders (FGID) are common conditions, with well-established diagnostic criteria. They are associated with impaired health-related quality of life and increased societal and healthcare costs. Their symptoms are probably related to altered 5-HT transmission and central processing of noxious visceral stimuli. Evaluation and treatment are best formulated using a biopsychosocial model that integrates gut function with psychosocial assessment. Psychological therapies may improve overall well-being and appear to help patients without significant psychiatric comorbidity. Antidepressants help comorbid anxiety and depressive disorders and have primary efficacy in improving the symptoms of FGID. Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients. Copyright © 2007 The Academy of Psychosomatic Medicine.

KW - therapeutic use: Antidepressive Agents

KW - drug therapy: Anxiety

KW - Comorbidity

KW - drug therapy: Depressive Disorder

KW - epidemiology: Gastrointestinal Diseases

KW - Health Care Costs

KW - Health Surveys

KW - Humans

KW - Psychiatry

KW - Psychotherapy

KW - Quality of Life

KW - drug therapy: Somatoform Disorders

U2 - 10.1176/appi.psy.48.2.93

DO - 10.1176/appi.psy.48.2.93

M3 - Article

VL - 48

SP - 93

EP - 102

JO - Psychosomatics

JF - Psychosomatics

SN - 0033-3182

IS - 2

ER -

Functional gastrointestinal disorders: An update for the psychiatrist

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this